RecruitingNCT05851430

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry


Sponsor

Galvanize Therapeutics, Inc.

Enrollment

1,000 participants

Start Date

Jun 23, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are: * PEF utilization and performance * Monitor safety outcomes and inform future generation devices. Participants will undergo the PEF procedure and be followed per institutional standard of care.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria4

  • Subject will undergo or has undergone PEF energy delivery utilizing Galvanize technology
  • Subject is expected to be available for follow-up per the enrolling physician's standard care practices
  • For prospective cohort, subject has a life expectancy of at least 3 months; for retrospective cohort, subject has completed at least three months of imaging following the PEF procedure
  • Signed informed consent is obtained, if required by IRB

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPEF ablation

Pulsed Electric Field (PEF) Ablation per institutional standard of care


Locations(8)

Eisenhower Medical Center

Rancho Mirage, California, United States

NCH Baker

Naples, Florida, United States

New York Presbyterian Langone Health

New York, New York, United States

Duke University Hospital

Durham, North Carolina, United States

Lankenau Institute for Medical Research (LIMR)

Wynnewood, Pennsylvania, United States

AnMed Health

Anderson, South Carolina, United States

UT Southwestern Medical Center

Dallas, Texas, United States

University of Texas-Tyler

Tyler, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05851430


Related Trials